Table 3 Investigation of cases with discordant 90-gene expression assay results
From: Gene expression profiling for the diagnosis of multiple primary malignant tumors
ID | Gender | Type | First/second/third | Age | Pathological diagnosis | Grade | Gene expression assay results | Stage | Treatment |
|---|---|---|---|---|---|---|---|---|---|
1 | Female | Metachronous | Second cancer | 67 | Left main bronchus mucoepidermoid carcinoma | Highly and moderately differentiated | Breast | I | Surgery & chemotherapy |
2 | Male | Synchronous | Second Cancer | 68 | Gastric antrum adenocarcinoma | Poorly differentiated | Colorectum | I | Surgery & chemotherapy |
3 | Female | Synchronous | Primary cancer | 50 | Gallbladder adenocarcinoma | Poorly differentiated | Gastroesophagus | II | Surgery |
4 | Female | Synchronous | Second cancer | 72 | Lung adenocarcinoma | Highly and moderately differentiated | Colorectum | I | Surgery & chemotherapy |
5 | Male | Metachronous | Primary Cancer | 58 | Esophageal squamous cell carcinoma | Squamous cell carcinoma | Head & neck | II | Surgery & chemotherapy |